Carlsmed, Inc.

CARL

As of the close on Sep 25, 2026

Price

$15.10

Market cap

$412M

P/E (diluted TTM)

—

A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given

EPS (TTM)

—

A per-share figure for one of the last four quarters is not shown, so no four-quarter total is given

Dividend yield

—

Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Carlsmed, Inc. Makes Money

Follow each dollar of revenue through to what shareholders keep.

From revenue to net income

Pick a year or quarter. Each band's width is its dollar amount.

Source: Carlsmed, Inc. — 10-Q filed Aug 5, 2026

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 2 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Independent insiders buying near the same time

2025-07-24–2025-07-24: 6 event(s) across 5 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing , filing , filing , filing , filing )

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2026-03-02	Cordonnier Michael · CEO, President	Common Stock	S — Open market or private sale	−197,855	13.29	SEC filing
2025-07-24	ROOT JONATHAN D · Director	Common Stock	P — Open market or private purchase	+466,666	15.00	SEC filing
2025-07-24	Mittendorff Robert II · Director	Common Stock	P — Open market or private purchase	+1,333,333	15.00	SEC filing
2025-07-24	Sidow Kevin · Director	Common Stock	P — Open market or private purchase	+13,333	15.00	SEC filing
2025-07-24	YOUNG PHILIP M · Director	Common Stock	P — Open market or private purchase	+53,333	15.00	SEC filing
2025-07-24	YOUNG PHILIP M · Director	Common Stock	P — Open market or private purchase	+6,666	15.00	SEC filing
2025-07-24	B Capital Healthcare I, L.P. · 10% owner	Common Stock	P — Open market or private purchase	+1,333,333	15.00	SEC filing

Showing 7 of 7 rows

Grants, exercises, tax & gifts

		Security	Code		Filing
2026-06-03	ROOT JONATHAN D · Director	Common Stock	A — Grant, award, or other acquisition	+13,698	SEC filing
2026-06-03	Sidow Kevin · Director	Common Stock	A — Grant, award, or other acquisition	+13,698	SEC filing
2026-06-03	YOUNG PHILIP M · Director	Common Stock	A — Grant, award, or other acquisition	+13,698	SEC filing
2026-06-03	OBOYLE KEVIN C · Director	Common Stock	A — Grant, award, or other acquisition	+13,698	SEC filing
2026-03-03	Cordonnier Michael · CEO, President	Common Stock	M — Exercise or conversion of derivative security	+33,264	SEC filing
2026-03-03	Cordonnier Michael · CEO, President	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−160,567	SEC filing
2026-03-03	Cordonnier Michael · CEO, President	Common Stock	M — Exercise or conversion of derivative security	+160,567	SEC filing
2026-03-03	Cordonnier Michael · CEO, President	Stock Option (Right to Buy)	M — Exercise or conversion of derivative security	−33,264	SEC filing

Showing 8 of 20 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.